# Niagen (NAGE) — Overview

NAGE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/nage

## Price

Last close $2.58 on Oct 15, 2026. 52-week range $2.53 – $7.60.

## Company profile

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $129.1M |
| Revenue (quarter) | $29.8M |
| Revenue growth (year over year) | -4.28% |
| Gross profit (trailing twelve months) | $82.9M |
| Gross margin | 64.24% |
| Net income (trailing twelve months) | $16.0M |
| Net income (quarter) | $963,000.00 |
| Net income growth (year over year) | -73.32% |
| Net margin | 12.39% |
| Return on equity | 21.80% |
| EPS (trailing twelve months) | $0.20 |
| Book value per share | $1.05 |
| P/E (trailing twelve months) | 12.8 |
| Price to book | 2.5 |
| Debt to assets | 22.57% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Niagen (NAGE) profitable?

Yes. Niagen earned $16.0M in net income over the trailing twelve months, a net margin of 12.39%.

### How much revenue does Niagen (NAGE) make?

Niagen generated $129.1M in revenue over the trailing twelve months, down 4.28% year over year.

### What is NAGE's P/E ratio?

Niagen trades at 12.8 times trailing twelve-month earnings, on an EPS of $0.20.

### How do I buy stock in Niagen (NAGE)?

NAGE trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).